Belnuc
Homepage arrow Réunions scientifiques arrow Congress Bruges 2009
Congress Bruges 2009 Version imprimable

Presentations of the XIVth symposium of BELNUC held in Bruges, May 2009

Content available to registered members only

 

Friday session:

- Image-based telecooperation, image fusion and multimodality image management. M. Feron (Leuven, B) 

Saturday sessions:

- Nuclear cardiology in women and diabetics: its place in the clinical guidelines. J. De Sutter (Ghent, B)

- The future of nuclear cardiology. D. Daou (Paris, F)

- Therapy with radiolabeled microspheres: view from the clinician. P. Hilgard (Essen, D)

- Therapy with radiolabeled microspheres: technical aspects. P. Flamen (Brussels, B)

- Octreotide analogues for radionuclide therapy: current status and future outlook. D.J. Kwekkeboom (Rotterdam, NL)

- Radioimmunotherapy for non-Hodgkin's lymphoma: the magic bullet ? M.J. Kersten (Amsterdam, NL)

- Therapy with I-131 for benign thyroid disorders. M. Edelbroek (Eindhoven, NL)

- Scintimammography. J. Buscombe (London, UK)

- FDG PET-CT for staging in breast cancer. T. Aukema (Amsterdam, NL)

- Sentinel node detection in breast cancer. O. Nieweg (Amsterdam, NL)

- The current role of bone scintigraphy in the detection of osseous metastases in breast cancer. F. Paycha (Paris, F)

 

Young investigators challenge:

- Unilateral brown fat on FDG-PET/CT in the follow-up of a pleural mesothelioma. A. De Waele (Leuven, B)

- PET(CT) based molecular imaging of tumour induced osteomalacia using Gallium-68 labeled somatostatin analogue. E. Woff (Brussels, B)

- Peripheral generalized lymphadenopathy (PGL) in a symptomatic HIV-1 patient as a potential differential diagnosis of lymphoma on FDG-PET. M. Al-Makhzomi (Leuven, B)

- Schnitzler's syndrome: an unusual cause of bone pain with suggestive nuclear imaging features. N. De Raedt (Leuven, B)

- Sentinel nodes in oral cavity carcinoma: SPECT/CT and a portable gamma camera to overcome interpretation difficulties. L. Vermeeren (NKI-AVL, NL)

 

Sunday session:

- Production of medical radioisotopes in nuclear reactors. B. Ponsard (SCK-CEN, Mol, B)

- Isotope recovery from nuclear reactors and production of generators. M. Kater (Covidien, Petten, NL)

- Production of medical radioisotopes in cyclotrons. J-M. Geets (IBA, Louvain-la-Neuve, B)

- Radiopharmaceuticals:EMEA-registration and future developments. A. Verbruggen (Leuven, B)

- General conclusions. F. De Coninck (SCK-CEN, Mol, B)

 

 
CMS by DMoon